Autonomix Medical Secures Canadian Patent for Nerve-Targeting Platform

Autonomix Medical has been granted Canadian Patent No. 3,183,802, which covers catheter-based transvascular access, adaptive therapy delivery, and real-time electrophysiological validation for nerve-targeted interventions.